Pipeline

Accelerating the journey to relief from chronic pain

Partner with Us

A NEW CATEGORY

Rethinking the Way We Treat Serious Health Conditions

AppliedVR is the first company to make virtual reality-based therapeutics widely available in healthcare. We’re committed to the development of safe, effective, clinically tested VRx treatments that improve the outcomes of those with serious health conditions. Working with more than 60,000 patients in 240 hospitals and 1,500 patient homes, we’ve generated significant real-world evidence that retraining the way the brain perceives pain is a promising new treatment path. Our RelieVRx (formerly EaseVRx) is the first and only FDA-authorized at-home immersive virtual reality (VR) pain treatment indicated as adjunctive treatment for chronic lower back pain (CLBP).1,2

WORLD-CLASS RESEARCH

Some of Our
Collaborators

Our Pipeline

PHASE 1
DISCOVERY
PHASE 2
EFFICACY
PHASE 3
PIVOTAL TRIAL
PHASE 4
FDA APPROVED

Chronic Lower Back Pain

General pain and anxiety management

Fibromyalgia

Opioid sparing treatment for chronic pain

Post Surgical Pain - Total Knee Replacement

Opioid sparing treatment for acute postoperative pain

Cancer Related Anxiety

Treatment for generalized anxiety

Rheumatoid Arthritis

General pain and anxiety management

Interested in Partnering
on Future Clinical Studies?

Get in Touch

Indication for Use

RelieVRx is a prescription-use immersive virtual reality system intended to provide adjunctive treatment based on cognitive behavioral therapy skills and other evidence-based behavioral methods for patients (age 18 and older) with a diagnosis of chronic lower back-pain (defined as moderate to severe pain lasting longer than three months). The device is intended for in-home use for the reduction of pain and pain interference associated with chronic lower back pain.


References

  1. RelieVRx [instructions for use]. Van Nuys, CA: AppliedVR, Inc.; 2021.

  2. AppliedVR Press Release. Accessed January 18, 2022.


RelieVRx was formerly known as EaseVRx.